---
title: "Ahlcon Parenterals (India) Ltd (524448) — Share Price, Financials & Analysis"
symbol: "524448"
company: "Ahlcon Parenterals (India) Ltd"
canonical: "https://tapetide.com/stocks/524448"
isin: "INE027C01011"
bse_code: "524448"
sector: "Healthcare"
industry: "Pharmaceuticals & Biotechnology"
generated_at: "2026-09-13T18:34:49.821Z"
---

# Ahlcon Parenterals (India) Ltd (524448)

Canonical page: https://tapetide.com/stocks/524448

## Company

- **BSE Code:** 524448
- **ISIN:** INE027C01011
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals & Biotechnology
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2006-03-01
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** ahlconindia.com

## About

Ahlcon Parenterals (India) manufactures and sells pharmaceutical preparations in India. It offers I.V. fluids, antimicrobial I.V. fluids, and eye/ear drops.

## Latest Price

## Key Insights

### Weaknesses

- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 5.35% over past five years.

## Growth Rates

| Metric | 1Y | 3Y | 5Y |
| --- | --- | --- | --- |
| net income growth | -9% | — | — |
| revenue growth | 4% | 10% | 5% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2013 | Jun 2013 | Sep 2013 | Dec 2013 | Mar 2014 | Jun 2014 | Sep 2014 | Dec 2014 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 30.34 | 28.74 | 29.46 | 30.62 | 31.15 | 28.4 | 28.24 | 33.2 |
| Expenses | 21.96 | 20.25 | 21.83 | 22.11 | 21.01 | 21.84 | 23.41 | 24.58 |
| Operating Profit | 8.38 | 8.49 | 7.63 | 8.51 | 10.14 | 6.56 | 4.83 | 8.62 |
| OPM % | 27.62 | 29.54 | 25.9 | 27.79 | 32.55 | 23.1 | 17.1 | 25.96 |
| Other Income | 0.01 | 0.19 | 0.09 | -0.02 | 0.03 | 0.08 | 0.23 | 0.26 |
| Interest | 0.65 | 0.51 | 0.5 | 0.38 | 0.19 | 0.05 | 0.11 | 0.07 |
| Depreciation | 0.91 | 0.87 | 0.85 | 0.87 | 0.85 | 1.09 | 1.09 | 1.08 |
| Profit before tax | 6.83 | 7.3 | 6.37 | 7.24 | 9.13 | 5.5 | 3.86 | 7.73 |
| Tax % | 33.67 | 31.23 | 41.13 | 35.22 | 33.95 | 29.27 | 26.94 | 15.27 |
| Net Profit | 4.53 | 5.02 | 3.75 | 4.69 | 6.03 | 3.89 | 2.82 | 6.55 |
| EPS in Rs | 6.29 | 6.97 | 5.21 | 6.51 | 8.37 | 5.4 | 3.92 | 9.1 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 50 | 62 | 79 | 108 | 120 | 116 | 118 | 135 | 150 | 156 |
| Expenses | 36 | 51 | 66 | 83 | 85 | 90 | 110 | 116 | 131 | 144 |
| Operating Profit | 15 | 11 | 13 | 25 | 35 | 26 | 9 | 19 | 19 | 12 |
| OPM % | 29 | 18 | 17 | 23 | 29 | 22 | 7 | 14 | 13 | 8 |
| Other Income | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 4 | 2 |
| Interest | 2 | 2 | 4 | 3 | 2 | 1 | 17 | 17 | 27 | 28 |
| Depreciation | 2 | 3 | 3 | 4 | 3 | 5 | 16 | 16 | 39 | 33 |
| Profit before tax | 11 | 6 | 7 | 19 | 30 | 21 | -24 | -14 | -43 | -48 |
| Tax % | 35 | 34 | 31 | 31 | 35 | 19 | -22 | 0 | 0 | 0 |
| Net Profit | 7 | 4 | 5 | 13 | 20 | 17 | -19 | -14 | -43 | -48 |
| EPS in Rs | 9.94 | 5.96 | 6.94 | 17.87 | 27.08 | 23.64 | -25.74 | -19.19 | -60.3 | -66.07 |
| Dividend Payout % | 15 | 25 | 14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 |
| Reserves | 27 | 30 | 34 | 47 | 66 | 83 | 64 | 50 | 7 | -41 |
| Borrowings | 11 | 26 | 24 | 18 | 43 | 206 | 251 | 274 | 289 | 296 |
| Other Liabilities | 14 | 18 | 18 | 23 | 26 | 43 | 37 | 33 | 23 | 53 |
| Total Liabilities | 59 | 81 | 83 | 96 | 143 | 339 | 359 | 364 | 326 | 315 |
| Fixed Assets | 35 | 50 | 50 | 46 | 50 | 278 | 289 | 275 | 268 | 246 |
| CWIP | 3 | 2 | 3 | 8 | 26 | 3 | 11 | 27 | 4 | 3 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 21 | 28 | 30 | 41 | 67 | 58 | 59 | 61 | 54 | 67 |
| Total Assets | 59 | 81 | 83 | 96 | 143 | 339 | 359 | 364 | 326 | 315 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 9 | — | — | — | — | — | — | — | — | — |
| Cash from Investing Activity | -2 | — | — | — | — | — | — | — | — | — |
| Cash from Financing Activity | -4 | — | — | — | — | — | — | — | — | — |
| Net Cash Flow | 2 | — | — | — | — | — | — | — | — | — |
| Free Cash Flow | 7 | — | — | — | — | — | — | — | — | — |
| CFO/OP | 85 | — | — | — | — | — | — | — | — | — |

### Ratios

| Item | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 79 | 85 | 60 | 87 | 102 | 99 | 81 | 90 | 62 | 67 |
| Inventory Days | 112 | 120 | 124 | 96 | 73 | 125 | 197 | 140 | 127 | 181 |
| Days Payable | 96 | 88 | 83 | 76 | 74 | 67 | 57 | 33 | 102 | 94 |
| Cash Conversion Cycle | 95 | 117 | 101 | 107 | 100 | 156 | 221 | 198 | 86 | 153 |
| Working Capital Days | 68 | 78 | 65 | 76 | 78 | 54 | 53 | 68 | 65 | 52 |
| ROCE % | 29 | 17 | 17 | 32 | 34 | 10 | -2 | 1 | -5 | -7 |

## Shareholding Pattern

### annual

| Category | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Dec 2025 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 69.51% | 69.51% | 64.9% | 64.9% | 66.81% | 66.81% | 66.81% |
| FIIs | 3.79% | 2.94% | 0.24% | 0.06% | 0.06% | 0% | 0% |
| DIIs | 0.04% | 0.05% | 0.04% | 0.05% | 0.05% | 0.05% | 0.05% |
| Public | 25.9% | 27.22% | 34.53% | 34.7% | 32.79% | 32.86% | 32.85% |
| Others | 0.76% | 0.28% | 0.28% | 0.28% | 0.28% | 0.28% | 0.28% |
| No. of Shareholders | 29203 | 26835 | 24329 | 23227 | 21548 | 20519 | 20369 |

### Quarterly

| Category | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 64.9% | 66.81% | 66.81% | 66.81% | 66.81% | 66.81% | 66.81% | 66.81% | 66.81% | 66.81% | 66.81% | 66.81% |
| FIIs | 0.06% | 0.06% | 0.06% | 0.06% | 0.06% | 0.06% | 0% | 0% | 0% | 0.01% | 0% | 0% |
| DIIs | 0.05% | 0.05% | 0.05% | 0.05% | 0.05% | 0.05% | 0.05% | 0.05% | 0.05% | 0.05% | 0.05% | 0.05% |
| Public | 34.7% | 32.8% | 32.8% | 32.78% | 32.79% | 32.78% | 32.86% | 32.85% | 32.86% | 32.85% | 32.85% | 32.85% |
| Others | 0.28% | 0.28% | 0.28% | 0.28% | 0.28% | 0.28% | 0.28% | 0.28% | 0.28% | 0.28% | 0.28% | 0.28% |
| No. of Shareholders | 23227 | 22745 | 21830 | 21265 | 21548 | 20908 | 20613 | 20441 | 20519 | 20963 | 20563 | 20369 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 2 / 6 / 11

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 126.83 | Buy |
| EMA (10) | 126.62 | Buy |
| SMA (20) | 132.78 | Sell |
| EMA (20) | 130.06 | Sell |
| SMA (50) | 136.76 | Sell |
| EMA (50) | 138.29 | Sell |
| SMA (100) | 157.21 | Sell |
| EMA (100) | 147.86 | Sell |
| SMA (200) | 158.24 | Sell |
| EMA (200) | 158.67 | Sell |

### Oscillators — summary: **Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 47.57 | Neutral |
| MACD (12,26,9) | -4.29 | Sell |
| Stochastic (14,3,3) | 23.03 | Neutral |
| ADX (14) | 22.96 | Neutral |
| Williams %R (14) | -38.2 | Neutral |
| ATR (14) | 7.09 | High Volatility |
| ROC (12) | -4.97 | Sell |
| Stoch RSI (14) | 100 | Sell |
| UO (7,14,28) | 44.45 | Neutral |

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 7 Jan - Certificate under SEBI Reg 74(5) for quarter ended 31 Dec 2025 from KFin regarding dematerialisation. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 7 Jan - Certificate under SEBI Reg 74(5) for quarter ended 31 Dec 2025 from KFin regarding dematerialisation.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b355027f-9e61-4f0b-8d52-f9b4a363807f.pdf) |
| 28 Jan - Board approved Q3/9M FY26 unaudited results; exceptional labour-code charge INR1,589L; Q3 consolidated loss after tax INR728L. | [Board Meeting Outcome for Outcome Of Board Meeting Held On 28Th January, 2026 28 Jan - Board approved Q3/9M FY26 unaudited results; exceptional labour-code charge INR1,589L; Q3 consolidated loss after tax INR728L.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/72cec190-eac6-4c82-9555-3916e21a9bfb.pdf) |
| 27 Dec 2025 - Trading window closed from 31 Dec 2025 until 48 hours after UFRs for quarter/nine-months ending 31 Dec 2025. | [Closure of Trading Window 27 Dec 2025 - Trading window closed from 31 Dec 2025 until 48 hours after UFRs for quarter/nine-months ending 31 Dec 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/45ba7ebb-7f52-4e16-928b-f0f3a5933dc1.pdf) |
| 21 Jan - Board meeting 28 Jan to approve unaudited Q3/nine-month results ended 31 Dec 2025; trading window closed till 30 Jan. | [Board Meeting Intimation for Board Meeting Intimation For Digicontent Limited To Be Held On Wednesday, 28Th January, 2026. 21 Jan - Board meeting 28 Jan to approve unaudited Q3/nine-month results ended 31 Dec 2025; trading window closed till 30 Jan.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/727b3750-0e91-4e4a-813f-6fe6a1a6c4d1.pdf) |
| — | [Results Of Board Meeting Held On 28Th January, 2026 28 Jan](https://www.bseindia.com/xml-data/corpfiling/AttachHis/884dd733-d47f-4e69-8ab7-c8a034c93efd.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/04f36860-639d-4ac2-b602-58d5f51d6650.pdf) |
| from bse | [Financial Year 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/12254f9e-f983-440a-b5b3-80d925bc9fd5.pdf) |
| from bse | [Financial Year 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3f009430-ecf2-44cd-aa4d-a593f5b9790a.pdf) |
| from bse | [Financial Year 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/542685/74193542685.pdf) |
| from bse | [Financial Year 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/542685/70151542685.pdf) |
| from bse | [Financial Year 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/542685/5426850320.pdf) |
| from bse | [Annual Report 2014 from bse](http://www.bseindia.com/bseplus/AnnualReport/524448/5244480314.pdf) |
| from bse | [Annual Report 2013 from bse](https://www.bseindia.com/bseplus/AnnualReport/524448/5244480313.pdf) |
| from bse | [Annual Report 2012 from bse](https://www.bseindia.com/bseplus/AnnualReport/524448/5244480312.PDF) |
| from bse | [Annual Report 2011 from bse](https://www.bseindia.com/bseplus/AnnualReport/524448/5244480311.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:34:49.821Z.